Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
THERANEXUS PUBLISHES ITS CASH POSITION AS OF 30 JUNE 2025
Lyon, France – 10 July 2024, 6.pm CET – Theranexus, a biopharmaceutical company developing drug candidates for rare neurological diseases, today published its cash position as of 30 June 2025. On 30 June 2025, total available funds stood at €2.1 M, compared with €2.9 million on 31 March 2025. In addition, a payment of €754k is expected in Q3 2025…
Actusnews Wire
10/07/2025
Oxurion kondigt het vervullen van de tweede opschortende voorwaarde aan in de…
Leuven, BELGIË – 10 juli 2025 – 17u45 CET – Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, kondigt aan dat de tweede opschortende voorwaarde in het kader van de overname van 72% van het kapitaal van Axiodis CRO door haar Franse dochteronderneming is vervuld…
Actusnews Wire
10/07/2025
Oxurion Announces the Fulfilment of the Second Condition Precedent in the…
Leuven, BELGIUM – July 10, 2025 at 5:45 PM CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, announces the fulfilment of the second condition precedent in the acquisition of 72% of the share capital of Axiodis CRO by its French subsidiary. The French Ministry for the Economy, Finance and Industrial and Digital…
Actusnews Wire
10/07/2025
Lumibird secures landmark contracts for OdiPro rangefinders on CV90 platforms in…
The Lumibird Group (FR0000038242 - LBIRD), European leader in laser technologies, announces that its subsidiary Lumibird Photonics Sweden AB has secured two major contracts awarded by Saab AB to supply its advanced OdiPro laser rangefinders to the armed forces of Sweden and Denmark. Valued at approximately EUR 10 million, these contracts cover…
Actusnews Wire
10/07/2025
Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing…
"ISB 2001 exemplifies the potential of our BEAT® protein platform to generate effective multispecificsTM that may overcome resistance and improve outcomes in hard-to-treat cancers," said Cyril Konto, M.D., President and CEO of IGI. "This agreement marks a defining milestone in IGI's scientific journey and reflects our team's deep commitment to delivering meaningful therapies for patients, Our partnership with AbbVie accelerates ISB 2001's path to patients and sharpens our focus on…
PR Newswire
10/07/2025
Healthcare BPO Market worth $694.3 billion by 2030 with 10.7% CAGR |…
Browse in-depth TOC on "Healthcare BPO Market" Browse in-depth TOC on "Healthcare BPO Market" 311 - Tables55 - Figures334 - Pages By Based on payer services,the healthcare BPO market is divided into claims management, integrated front-end services, back-office operations, member management services, product development and business acquisition services, provider management services, care management services, billing and accounts management services, and HR services...
PR Newswire
10/07/2025
New Research in JNCCN Offers Reassurance About Localized Prostate Cancer…
The researchers studied 62,839 people diagnosed with non-metastatic prostate cancer in Sweden between the years 2000-2020. All were placed within a defined risk category, had a life expectancy of more than three years, and were treated according to evidence-based, expert consensus-driven recommendations from the NCCN Guidelines® for Prostate Cancer. Those with low- and intermediate-risk cancer were six times more likely to die of other causes than prostate cancer. Those with high-risk cancer…
PR Newswire
10/07/2025
Revolutionary Therapy Service Launches to Tackle UK Mental Health Crisis
The service directly addresses the current mental health crisis, where therapy waiting times average 14-22 weeks for adults and up to 6 months for children and young people. Towards introduces "The Towards Pledge" – clients can register in 5 minutes, hear from a qualified therapist within 5 hours, and begin their first session within 5 days. The service directly addresses the current mental health crisis, where therapy waiting times average 14-22 weeks for adults and up to 6 months for…
PR Newswire
10/07/2025
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up
While U.S. cancer death rates continue to decline, global cancer cases are expected to rise sharply. As well, early-onset diagnoses in younger patients are climbing at a troubling pace. Now, industry analysts are estimating the global oncology drug market could surpass US$900 billion in revenue by 2034. WhileU.S. cancer death rates continue to decline,global cancer cases are expected to rise sharply. As well, early-onset diagnoses in younger patients areclimbing at a troubling pace...
PR Newswire
10/07/2025
Dräger Receives Frost & Sullivan's 2025 Global Company of the Year Recognition…
Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: visionary innovation and customer impact. Dräger excelled in both, demonstrating its ability to align its innovation roadmap with market demand while executing with precision, scalability, and clinical relevance. "Keeping the customer need in mind, Dräger's designs focus on a range of consumer needs, including scalability, flexibility, low infection rates, low readmission rates…
PR Newswire
10/07/2025
Lifecykel Launches Ground Breaking Mongolian Training Program with UFC Legends…
Designed for high achievers and self-optimizers, the camp invites individuals dedicated to growth, discipline, and physical excellence. At the heart of the program is Shilajit, a cornerstone of traditional Mongolian wellness, often referred to as "the destroyer of weakness" for its dense mineral profile and adaptogenic power. Danaa has developed a signature training regimen that merges ancient warrior techniques with cutting-edge biohacking strategies. Those interested in participating…
PR Newswire
10/07/2025
e-therapeutics De-risks Clinical Path for GalOmic Candidate ETX-312 with…
ETX-312 well tolerated at exaggerated dose levels in GLP-compliant toxicology studiesGMP manufacturing of clinical trial batch successfully completedOn track for CTA submission in Q4 2025 LONDON, July10, 2025(GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, today announced significant progress on its lead candidate, ETX-312, a GalOmic siRNA therapy for the treatment of metabolic...
Nasdaq GlobeNewswire
10/07/2025
Jazz Pharmaceuticals Names Renee Gala as President and Chief Executive Officer
DUBLIN, July 10, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Jazz Board of Directors has unanimously selected Renee Gala, Jazz's President and Chief Operating Officer, as the President and Chief Executive Officer, effective August 11, 2025, when she will also join the Board. She will succeed co-founder, Chairperson and CEO Bruce Cozadd, who informed the Board in December 2024 of his intent to retire as CEO upon the identification of the Company's next…
PR Newswire
10/07/2025
Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of…
– Data from an analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed improvements in cognition and behavior at Week 68 –– These findings support the inclusion of key secondary endpoints assessing cognition and behavior in the Phase 3 EMPEROR study and contrast with outcomes observed in natural history data – CAMBRIDGE, Mass. and BEDFORD, Mass., July10, 2025(GLOBE NEWSWIRE) --Biogen Inc.(Nasdaq: BIIB) andStoke Therapeutics, Inc...
Nasdaq GlobeNewswire
10/07/2025
MolecuLight Appoints Dr. Julia Wright as Chief Medical Officer to Accelerate…
Dr. Wright brings over two decades of robust clinical and leadership experience, underpinned by a distinguished background in Internal Medicine, continuing to practice as a Hospitalist Physician. She consistently stays on the leading edge of healthcare changes, championing patient-centered care, innovation, quality and safety initiatives, and the strategic implementation of clinical best practices across vast, multi-site healthcare organizations and health plans. This unique perspective aligns…
PR Newswire
10/07/2025
Nature's Best shares science-backed advice to prevent premature ageing, from the…
Sally Lott, Product Developer at Nature's Best, shares five skin-ageing habits and how to fix them. Sally Lott, Product Developer at Nature's Best, shares five skin-ageing habits and how to fix them. "Many people look for the latest serum or skincare tool but forget the basics – sleep, hydration, and inner health," says Lott. "Collagen loss starts in your 20s, but we often don't act until lines appear. It is time to rethink our approach. Here are five everyday habits that could…
PR Newswire
10/07/2025
Medical Device Manufacturers Accelerate R&D and Speed to Market via Live…
Better than industry-standard rapid prototyping, Elevaris Medical Devices offers the XLerator live prototyping program, where industry engineers collaborate on-site with Elevaris experts to utilize a development environment within the company's manufacturing space. Throughout the accelerated experience Elevaris provides a complete team of technical support, including project engineers, process development engineers, manufacturing technicians, and machine operators. The offering also includes…
PR Newswire
10/07/2025
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
REYKJAVIK, ICELAND (July 10, 2025)— Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda Jónsdóttir as Chief Financial Officer (CFO). Linda is a highly experienced international executive with a strong background in finance and corporate leadership. She has held senior roles across a range of industries, including banking, food technology, transportation,...
Nasdaq GlobeNewswire
10/07/2025
21st.BIO launches precision fermentation program for bovine alpha-lactalbumin
Alpha-lactalbumin is a highly functional milk protein rich in essential amino acids. It is easy to digest and is linked to immune and cognitive development benefits. Bovine α-lac is currently used in infant nutrition, functional food and health-focused applications. 21st.BIO is optimizing the Novonesis-developed strain for industrial fermentation, scale-up, and commercialization – enabling companies around the world to bring precision fermented α-lac to market and with the ambition to be cost…
PR Newswire
10/07/2025
Esports World Cup 2025 Kicks Off in Riyadh With $70 Million Prize Pool…
EWC 2025 brings together the world's top 200 Clubs to compete in a first-of-its-kind cross-title format. At the heart of the competition is the Club Championship, where teams accumulate points across multiple games to become the EWC Club Champion, claim a $7 million grand prize and hoist the coveted EWC Club Championship trophy. The $70+ million prize pool also includes $38+ million for individual Game Championships, $5 million in global qualifier rewards, and $450,000 in MVP bonuses…
PR Newswire
10/07/2025
Outfit7: New Hair, Who's This? The Hair Salon Arrives in My Talking Angela 2
You can move freely between stations, experimenting and refining until your masterpiece is complete. Then, save it all in the Glam Room for future slayage - your go-to spot for all your best looks. You can move freely between stations, experimenting and refining until your masterpiece is complete. Then, save it all in the Glam Room for future slayage - your go-to spot for all your best looks. Imperfectly Iconic: Style With Confidence In My Talking Angela 2, style isn't about perfection,...
PR Newswire
10/07/2025
DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK Research…
DXS INTERNATIONAL PLC (AQSE: DXSP) ExpertCare featured in Innovate UK Research ProjectDXS International plc ("DXS" or "the Company"), a leading provider of digital clinical decision support solutions, is thrilled to announce that its leading-edge digital health solution, ExpertCare, has been independently reviewed by the prestigious York Health Economics Consortium (YHEC) with results that confirm its powerful impact on both clinical outcomes and NHS cost-efficiency. Funded…
Nasdaq GlobeNewswire
10/07/2025
Bracco Imaging Earns EcoVadis Platinum Medal for Global Sustainability…
Bracco earned an overall score of 83 out of 100 in its EcoVadis assessment, with particularly strong performance in the Environment category, where it scored 91/100. The Platinum Medal reflects the company's high standards across four sustainability pillars: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement—areas in which Bracco has made strategic investments to drive responsible growth and long-term impact. Bracco earned an overall score of 83 out of 100 in its…
PR Newswire
10/07/2025
Tecan announces CEO transition as part of succession planning
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland, July 10, 2025 –The Tecan Group (SIX Swiss Exchange: TECN) today announced a planned CEO transition, marking a new chapter in the company’s successful growth story. After nearly 12 years with Tecan, including 6 ½ years as CEO, Dr. Achim von Leoprechting has decided to step down as CEO, effective August 1, 2025, to focus on new projects.Dr. von Leoprechting will remain...
Nasdaq GlobeNewswire
10/07/2025
Altri Comunicati
